Angiotensin II receptor blockers and cardiovascular outcomes: the evidence now and in the future

The blood-pressure-lowering efficacy of both angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin II receptor blockers (ARBs) has been clearly demonstrated in recent years, although there is evidence that within the ARB class the individual therapies are not necessarily identical in term...

Full description

Bibliographic Details
Main Author: Michael Weber
Format: Article
Language:English
Published: SAGE Publications 2001-06-01
Series:Journal of the Renin-Angiotensin-Aldosterone System
Online Access:http://jra.sagepub.com/content/2/2_suppl/S12.full.pdf